Skip to main content
Fig. 2 | Diabetology & Metabolic Syndrome

Fig. 2

From: Targeting hepatic sulfane sulfur/hydrogen sulfide signaling pathway with α-lipoic acid to prevent diabetes-induced liver injury via upregulating hepatic CSE/3-MST expression

Fig. 2

Body weight, glycemic status, plasma insulin and pancreas histology. A Body weight, B food consumption C fasting blood glucose D liver weight E relative liver weight, F HbA1c, G plasma insulin, H HOMA-β, I hepatic glycogen content and J representative micrographs of PAS-stained images of pancreatic tissues at 400 × magnification. Black arrows point to pancreatic islets. HC = Healthy control; T2DM = Untreated diabetic control; T2DM + ALA = Diabetic rats treated with alpha-lipoic acid; DT2M + PPG = Diabetic rats treated with propargylglycine. #p < 0.0001 vs. T2DM, $p < 0.001 vs. T2DM, *p < 0.05 vs. T2DM

Back to article page